Survo
Research description
Survo (BI 456906; CAS 2805997-46-8; PubChem CID 168429725) is a synthetic, acylated 29-amino-acid research peptide derived from the glucagon backbone, engineered as a dual agonist at glucagon receptors (GCGR) and GLP-1 receptors (GLP-1R). A C18 fatty diacid side chain at position 24, linked via a hydrophilic glycine-serine spacer, enables albumin binding for extended circulating presence and once-weekly research protocol administration. A non-coded amino acid (1-aminocyclobutane-1-carboxylic acid; Ac4c) at position 2 differentiates Survo from native glucagon and enhances receptor selectivity. Developed by Boehringer Ingelheim under licence from Zealand Pharma, Survo is in Phase 3 clinical research programmes (SYNCHRONIZE series for body-weight management; LIVERAGE programme for MASH) and holds FDA Breakthrough Therapy Designation for non-cirrhotic MASH with moderate to advanced fibrosis. It is not approved by the FDA for any indication as of March 2026. FOR RESEARCH USE ONLY. Not for consumption, human or animal administration, or any application outside a controlled non-clinical laboratory setting. Researchers require institutional approval, appropriate biosafety protocols, and batch COA documentation before any laboratory use.
Research use only
For laboratory research use only. Not for human or veterinary use. Not a drug, supplement, food, or cosmetic. Product descriptions summarise published laboratory literature and are not a recommendation for any use in humans or animals.
Unit price
$73.00
Quantity
Buy more, save more
| Pack | Unit price | Total | Saved |
|---|
Every lot released under this product line, newest first. The lot number printed on your vial label resolves to the certificate below — purity, net content, endotoxin, appearance and the number of vials pulled for the conformity panel.
No lots have been published for this product yet.
- CAS number
- Not assigned for this compound
Handling notes
Reconstitution figures for any fill weight and diluent volume can be worked out on the concentration calculator. Solubility and storage data on this page describe laboratory handling of the material only.
This compound is not light-sensitive under normal laboratory lighting. Standard clear containers are acceptable for reconstituted stock.
Sealed storage
- Temperature
- Shelf life
After reconstitution
- Temperature
- Working window
- Light sensitive
- No
In transit
- Note
- Free shipping
- US orders over $200
Related
Studied alongside this compound
-
Adipotide FTPP
Adipotide is a synthetic chimeric peptidomimetic studied in preclinical research models for its targeted interaction with white-adipose-tissue vasculature. Its structure combines the CKGGRAKDC homing domain with the D(KLAKLAK)₂ proapoptotic effector domain. PubChem lists Adipotide under CID 163360068, while RUO catalogues commonly reference the acetate salt under CAS 859216-15-2. For research use only. Not approved for human use.
Add 5mg -
Dermorphin
Dermorphin is a naturally occurring opioid heptapeptide derived from Phyllomedusa sauvagei frog skin secretions. Defined by its unique D-Ala² substitution, it exhibits exceptional μ-opioid receptor selectivity and potency in animal models. Dermorphin is not FDA-approved for human or veterinary use, has no recognized clinical pathway in the U.S., and remains a Class I banned substance in equine sport. This resource provides educational and regulatory information for research and professional reference only.
Add 5mg -
Thymalin
Thymalin is a heterogeneous thymic polypeptide complex originally isolated from young calf thymus tissue. Unlike single synthetic peptides, it has no single molecular formula or PubChem CID and is composed of multiple bioactive short peptide fractions, including KE dipeptide, EW dipeptide, and EDP. It is distinct from Thymulin, a defined zinc-dependent nonapeptide often confused with Thymalin in the peptide market. In the United States, Thymalin is not FDA-approved and has been specifically cited in FDA enforcement action as an unapproved new drug, making accurate, educational, and non-therapeutic positioning essential.
Add 10mg -
GLP-1-Sm/BPC-157
GLP-1-Sm/BPC-157 is a 17 mg dual-component peptide research blend supplied as a lyophilized laboratory material. Listed for research catalogue reference only, with identity, purity, and batch details to be confirmed by Certificate of Analysis.
Add 17mg